3 ms·
Perhaps, but by that standard all basic research in medicine with no short-term application to humans is "just milking gullible people". There's not much in th
by zozbot234 5y ago
Perhaps, but by that standard all basic research in medicine with no short-term application to humans is "just milking gullible people". There's not much in there that's specific to SENS.
- jacquesm 5y agoNot really, because the bulk of that research is at least based on solid scientific principles whereas what de Grey has been peddling always read as 'made for investors' rather than aiming for specific results. I always figured that Mollers sky car would fly long before de Grey would deliver a result (and I consider Moller to be longest running investor scam in history besides the Catholic church).
- zozbot234 5y agoThe fact that the SENS approach can even lead to "made for investors", plausibly-viable biotech spinoffs is, if anything, a validation of its scientific plausibility. Don't get me wrong, you could fairly describe it as a niche, fringe, unpopular approach and perhaps discount it on that basis, but it's at least not so fringe as to be entirely useless.
- jacquesm 5y agoNo, it's mostly a proof of the fact that investors do not usually have a good grasp of what they are investing in. See also: Theranos, Moller, uBeam and many others besides. And in the case of de Grey specifically, that Pascal's wager is alive and well.